Log in or Sign up for Free to view tailored content for your specialty!
Arrhythmia Disorders News
Data show potential cardioprotective effects of birth control use
A large analysis of UK Biobank data indicated no increased CV risk from birth control and even suggested a potential cardioprotective effect from oral contraceptive use, researchers reported.
FDA approves cryoablation system for paroxysmal AF with expandable balloon catheter
Boston Scientific announced it received FDA approval for its cryoablation system indicated for the treatment of patients with paroxysmal atrial fibrillation.
Log in or Sign up for Free to view tailored content for your specialty!
Subcutaneous implantable devices safe for patients with congenital heart disease
Subcutaneous implantable cardioverter defibrillators are effective in preventing arrhythmic death in people with congenital heart disease, with the devices successfully terminating all life-threatening ventricular arrhythmias, data show.
FDA approves several radiofrequency AF ablation catheters for use without fluoroscopy
Biosense Webster announced several of its products in its cardiac ablation portfolio have received FDA approval for use without fluoroscopy.
For shock-resistant AF, traditional measures ‘fail to capture’ ablation’s true benefit
Implantable device data show patients with shock-resistant atrial fibrillation fare better than conventional analyses demonstrate, experiencing a marked reduction in atrial tachyarrhythmia burden despite modest arrhythmia-free survival.
Top news July 2023: FDA approves leadless pacing system, AHA statement on vaping and more
Healio | Cardiology Today has compiled a list of the top headlines in cardiology of July 2023.
FDA identifies GE HealthCare recall of sensors for defibrillators as class I
GE HealthCare announced a recall of arterial oxygen saturation sensors due to a malfunction that may reduce the amount of energy sent to the heart during defibrillation without notification to the care provider.
Abbott recall of LAAO catheters designated class I
Abbott announced a recall of its cardiac catheter used in procedures for left atrial appendage occlusion due to risk for air embolism, potentially causing stroke or death.
US survival rates of out-of-hospital cardiac arrest lower among Asian vs. white adults
Asian individuals experience poorer outcomes after out-of-hospital cardiac arrest in the U.S. compared with white individuals, despite similar rates of bystander CPR, researchers reported.
Catheter for mapping of complex cardiac arrhythmias launched
Biosense Webster announced the U.S. launch of a catheter to help electrophysiologists with mapping complex cardiac arrhythmias.